As Bristol Myers Squibb Co (BMY) Shares Rose, California Public Employees Retirement System Decreased Stake by $15.67 Million

Bristol-Myers Squibb Company (NYSE:BMY) Corporate LogoDuring 2018 Q2 the big money sentiment decreased to 0.78. That’s change of 0.05, from 2018Q1’s 0.83. 94 investors sold all, 550 reduced holdings as BMY ratio is negative. 396 rose positions while 108 funds amassed positions. Funds hold 1.14 billion shares thus 1.65% more from 2018Q1’s 1.12 billion shares. Moreover, Hightower Ltd Com has 0.35% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 817,755 shs. Maple Capital holds 0.1% in Bristol-Myers Squibb Company (NYSE:BMY) or 6,981 shs. Fulton National Bank Na stated it has 0.08% of its capital in Bristol-Myers Squibb Company (NYSE:BMY). 4,959 are owned by Mathes Communication. Jpmorgan Chase reported 0.26% of its capital in Bristol-Myers Squibb Company (NYSE:BMY). Private Asset Management accumulated 153,490 shs or 1.5% of the stock. 596,269 are held by Shufro Rose And Ltd Llc. Curbstone Financial Mngmt accumulated 11,814 shs or 0.18% of the stock. Illinois-based Nuveen Asset Mgmt Ltd Liability Corp has invested 0.02% in Bristol-Myers Squibb Company (NYSE:BMY). Savant Cap Ltd Liability Corporation holds 0.13% or 10,641 shs. Cedar Hill Limited Liability Corporation holds 3,784 shs. Raymond James & Assocs owns 1.08M shs for 0.1% of their capital. Factory Mutual Insurance Communication has invested 0.33% in Bristol-Myers Squibb Company (NYSE:BMY). 88,490 are owned by Nippon Life Glob Invsts Americas. Obermeyer Wood Counsel Lllp owns 18,400 shs or 0.09% of their US capital.

In 2018Q2 SEC form is reported California Public Employees Retirement System’s holdings in Bristol Myers Squibb Co (BMY) which was reduced by 6.61%. The company’s stock popped up 12.85% while California Public Employees Retirement System sold 284,877 shares. The institutional investor is holding 4.02 million shares, compared to the 4.31 million from the previous quarter. And the announced value of the major pharmaceuticals company is $222.69M for the 2018Q2. $86.64 billion is the market cap of Bristol Myers Squibb Co. BMY is hitting $53.08 during the last trading session, after decreased 0.32%.Bristol-Myers Squibb Company has 10.46M shares volume, 26.99% up from normal. BMY is downtrending and has moved 4.27% since December 8, 2017. The stock underperformed the S&P500 by 19.89%.

California Public Employees Retirement System manages about $72.33B US Long portfolio. It increased its stake in Republic Services Inc (NYSE:RSG) by 104,804 shares to 748,599 shares, valued at $51.17M in 2018Q2, according to the filing. California Public Employees Retirement System has risen its stake in Aflac Inc (NYSE:AFL) and also increased its holding in American Water Works Co Inc (NYSE:AWK) by 91,270 shares in the quarter, for a total of 545,607 shares.

On February, 4 is anticipated Bristol-Myers Squibb Company (NYSE:BMY)’s earnings report, according to Faxor. Last year’s earnings per share was $0.68, while now analysts expect change of 23.53 % up from current $0.84 earnings per share. The profit will be $1.37 billion for BMY if $0.84 earnings per share becomes true. After $1.09 earnings per share was revealed previous quarter, analysts now see negative EPS growth of -22.94 % for Bristol-Myers Squibb Company.

For more Bristol-Myers Squibb Company (NYSE:BMY) news released briefly go to:,,, or The titles are as follows: “Bristol-Myers Squibb’s Opdivo + Yervoy flunks late-stage lung cancer study; shares off 3% after hours – Seeking Alpha” released on November 26, 2018, “Bristol-Myers Squibb to Take Part in Evercore ISI HealthCONx Conference – Business Wire” on November 20, 2018, “Bristol-Myers Squibb Company (BMY) Presents at Evercore ISI HealthCONx Conference (Transcript) – Seeking Alpha” with a publish date: November 28, 2018, “Why Pfizer Is Up 19% in 2018 So Far – Motley Fool” and the last “Can These 2 Battered Biotech Stocks Recover? – Motley Fool” with publication date: November 14, 2018.

Bristol-Myers Squibb Company (NYSE:BMY) Ratings Coverage

In total 10 analysts cover Bristol-Myers Squibb (NYSE:BMY). “Buy” rating has 3, “Sell” are 0, while 7 are “Hold”. 30% are bullish. 12 are the (NYSE:BMY)’s analyst reports since July 23, 2018 according to StockzIntelligence Inc. In Monday, October 22 report Citigroup downgraded the stock to “Neutral” rating. On Monday, July 23 the stock has “Market Perform” rating by BMO Capital Markets. In Tuesday, October 23 report BMO Capital Markets maintained it with “Market Perform” rating and $54 target. On Tuesday, November 27 the firm earned “Hold” rating by Guggenheim. On Wednesday, August 8 the stock has “Neutral” rating by Atlantic Securities. On Friday, October 12 the firm earned “Equal-Weight” rating by Barclays Capital. On Tuesday, November 6 Morgan Stanley maintained Bristol-Myers Squibb Company (NYSE:BMY) with “Equal-Weight” rating. On Friday, July 27 the company was maintained by Credit Suisse. The company rating was maintained by JP Morgan on Monday, October 8. On Friday, November 16 the firm has “Market Perform” rating given by BMO Capital Markets.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.